search
Back to results

Home-Based Kidney Care in Native American's of New Mexico (HBKC)

Primary Purpose

Chronic Kidney Diseases

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Home-Based Kidney Care
Sponsored by
University of New Mexico
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Chronic Kidney Diseases focused on measuring Diabetes, American Indians, Disparity, microalbuminuria, Telemedicine, Community health representative (CHR), Patient Activation Measure (PAM), Home base kidney care

Eligibility Criteria

21 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • (1) live in a household with 1 participant
  • (2) age 21 to 80 years
  • (3) negative pregnancy test in women of child-bearing potential
  • (4) diagnosed diabetics or HbA1c >7
  • (5) BMI >27 kg/m2 and UACR of >/= 30

Exclusion Criteria:

  • (1) life expectancy < 1 year
  • (2) pregnancy or absence of reliable birth control in women of child-bearing potential
  • (3) malignancy except non-melanoma skin cancer
  • (4) blind
  • (5) ESRD and on dialysis
  • (6) kidney transplant recipient
  • (7) unwilling or unable to give informed consent.

Sites / Locations

  • University of New Mexico

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Usual Care / Delayed Intervention

Home-Based Kidney Care Intervention

Arm Description

Participants randomized to the control group will receive usual care by their provider for 12 months. They will also attend one group class taught by CHRs in which they will learn basic information about diabetes prevention. DI participants will receive publicly-available literature that reinforces the information given in class, and they will have no other contact with study staff aside from during study data collection visits at baseline and 12 months. After 12 months of usual care, patients will enter into the delayed intervention where they will complete 12 months of Home-Based Kidney Care (HBKC).

All subjects randomized to the HBKC arm will be visited by a CHR in their home at least every two weeks for the duration of the 12 month intervention. Each visit will last 30 minutes to one hour and participant preference will be incorporated into the HBKC intervention arm by allowing participants to prioritize the order in which curriculum topic areas will be emphasized by the CHRs. Topics from currently available NIDDK and IHS kidney education materials will include: (1) Kidney 101, (2) weight management, (3) exercise, (4) healthy eating, (5) medication management, (6) coping with stress, (7) risk factor management (i.e.- blood pressure, hyperlipidemia), (8) alcohol and substance abuse, (9) smoking cessation, and related health concerns.

Outcomes

Primary Outcome Measures

The Patient Activation Measure (PAM)
Assesses an individual's knowledge, skill, and confidence for managing one's health and healthcare.

Secondary Outcome Measures

Diabetes lab measures
changes in clinical values
Kidney disease lab measures
changes in clinical values
Blood pressure
changes in clinical values
Lipid profile
changes in clinical values
Clinical Phenotype of Inflammation
changes in the value of marker of inflammation
Waist Circumference
changes in the value of waist circumference
Psychological measures
Changes in kidney disease specific quality of life (KDQOL) measures
Nutritional Measures
Changes in 24 hours recall of diet questionnaire

Full Information

First Posted
June 2, 2017
Last Updated
May 12, 2023
Sponsor
University of New Mexico
Collaborators
Albuquerque Area Southwest Tribal Epidemiology Center (AASTEC)
search

1. Study Identification

Unique Protocol Identification Number
NCT03179085
Brief Title
Home-Based Kidney Care in Native American's of New Mexico (HBKC)
Official Title
Home-Based Chronic Kidney Disease (CKD) Care in Native American's of New Mexico- A Disruptive Innovation
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Completed
Study Start Date
August 22, 2017 (Actual)
Primary Completion Date
December 1, 2022 (Actual)
Study Completion Date
December 1, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of New Mexico
Collaborators
Albuquerque Area Southwest Tribal Epidemiology Center (AASTEC)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
People reach End Stage Renal Disease (ESRD) due to progressive chronic kidney disease (CKD). CKD is associated with increased risk for heart disease and death. The burden of chronic kidney disease is increased among minority populations compared to Caucasians. New Mexico American Indians are experiencing an epidemic of chronic kidney disease due primarily to the high rates of obesity and diabetes. The present study entitled Home-Based Kidney Care is designed to delay / reduce rates of ESRD by early interventions in CKD. Investigators propose to assess the safety and efficacy of conducting a full-scale study to determine if home based care delivered by a collaborative team composed of community health workers, the Albuquerque Area Indian Health Board and University of New Mexico faculty will decrease the risk for the development and the progression of CKD.
Detailed Description
Hypothesis: Specific Aim 1: Screen 600 participants from four different American Indian tribes in New Mexico to identify incident cases of CKD and identify participants for the proposed study of HBKC; Specific Aim 2: Conduct a 12 month study of HBKC among 240 Native Americans randomized in a 1:1 allocation to HBKC group versus Delayed Intervention (DI) group to demonstrate improvement in Patient Activation Measures (PAM) and adherence to treatment. We will demonstrate that CKD clinical risk profiles will improve with HBKC as compared to DI at 12 months and 4 months post intervention (16 months); Specific Aim 3: To demonstrate that HBKC will improve psychological factors that map onto important cultural variations in treatment efficacy and health outcomes. Specifically, we will show improvement in potential mediators (treatment engagement, self-efficacy, coping and increased knowledge) and moderators (stigma, and chronic stress, and depression) of health disparity and outcome. Study Outcomes: (1) The patient activation measures and adherence; (2) Changes in clinical phenotypes including Cr, UACR, A1c, body weight, BMI, fasting glucose, blood pressure (BP), plasma lipids, and inflammatory markers; (3) Changes in the quantitative traits such as diet and scores from a battery of mental-health, self-efficacy, and quality of life instruments. Health Impact: The active participation of New Mexico tribal leadership and the Albuquerque Area Indian Health Board, as well as the accessibility to native CHR personnel, render the outcomes that will be demonstrated by this proposal easily sustainable over the long term. If successful, this program has the potential to change best-practices for CKD progression and to reduce health disparities in a cost-effective and sustainable manner.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Kidney Diseases
Keywords
Diabetes, American Indians, Disparity, microalbuminuria, Telemedicine, Community health representative (CHR), Patient Activation Measure (PAM), Home base kidney care

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Model Description
Participants randomized to control group will receive standard care for 12 months before entering into the delayed intervention. Participants randomized to the intervention will receive the intervention during the first 12 months.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
206 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Usual Care / Delayed Intervention
Arm Type
Active Comparator
Arm Description
Participants randomized to the control group will receive usual care by their provider for 12 months. They will also attend one group class taught by CHRs in which they will learn basic information about diabetes prevention. DI participants will receive publicly-available literature that reinforces the information given in class, and they will have no other contact with study staff aside from during study data collection visits at baseline and 12 months. After 12 months of usual care, patients will enter into the delayed intervention where they will complete 12 months of Home-Based Kidney Care (HBKC).
Arm Title
Home-Based Kidney Care Intervention
Arm Type
Experimental
Arm Description
All subjects randomized to the HBKC arm will be visited by a CHR in their home at least every two weeks for the duration of the 12 month intervention. Each visit will last 30 minutes to one hour and participant preference will be incorporated into the HBKC intervention arm by allowing participants to prioritize the order in which curriculum topic areas will be emphasized by the CHRs. Topics from currently available NIDDK and IHS kidney education materials will include: (1) Kidney 101, (2) weight management, (3) exercise, (4) healthy eating, (5) medication management, (6) coping with stress, (7) risk factor management (i.e.- blood pressure, hyperlipidemia), (8) alcohol and substance abuse, (9) smoking cessation, and related health concerns.
Intervention Type
Behavioral
Intervention Name(s)
Home-Based Kidney Care
Intervention Description
All subjects randomized to the HBKC arm will be visited by a community health representative in their home at least every two weeks for the duration of the 12 month intervention. Each visit will last 30 minutes to one hour and cover materials like, (1) Kidney 101, (2) weight management, (3) exercise, (4) healthy eating, (5) medication management, (6) coping with stress, (7) risk factor management (i.e.- blood pressure, hyperlipidemia), (8) alcohol and substance abuse, (9) smoking cessation, and related health concerns.
Primary Outcome Measure Information:
Title
The Patient Activation Measure (PAM)
Description
Assesses an individual's knowledge, skill, and confidence for managing one's health and healthcare.
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Diabetes lab measures
Description
changes in clinical values
Time Frame
12 months
Title
Kidney disease lab measures
Description
changes in clinical values
Time Frame
12 months
Title
Blood pressure
Description
changes in clinical values
Time Frame
12 months
Title
Lipid profile
Description
changes in clinical values
Time Frame
12 months
Title
Clinical Phenotype of Inflammation
Description
changes in the value of marker of inflammation
Time Frame
12 months
Title
Waist Circumference
Description
changes in the value of waist circumference
Time Frame
12 months
Title
Psychological measures
Description
Changes in kidney disease specific quality of life (KDQOL) measures
Time Frame
12 months
Title
Nutritional Measures
Description
Changes in 24 hours recall of diet questionnaire
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: (1) live in a household with 1 participant (2) age 21 to 80 years (3) negative pregnancy test in women of child-bearing potential (4) diagnosed diabetics or HbA1c >7 (5) BMI >27 kg/m2 and UACR of >/= 30 Exclusion Criteria: (1) life expectancy < 1 year (2) pregnancy or absence of reliable birth control in women of child-bearing potential (3) malignancy except non-melanoma skin cancer (4) blind (5) ESRD and on dialysis (6) kidney transplant recipient (7) unwilling or unable to give informed consent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Vallabh Shah, PhD
Organizational Affiliation
University of New Mexico
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of New Mexico
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87131
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
Anonymized data will be available to share once the tribal leadership approves it.
Citations:
PubMed Identifier
27197911
Citation
Cukor D, Cohen LM, Cope EL, Ghahramani N, Hedayati SS, Hynes DM, Shah VO, Tentori F, Unruh M, Bobelu J, Cohen S, Dember LM, Faber T, Fischer MJ, Gallardo R, Germain MJ, Ghahate D, Grote N, Hartwell L, Heagerty P, Kimmel PL, Kutner N, Lawson S, Marr L, Nelson RG, Porter AC, Sandy P, Struminger BB, Subramanian L, Weisbord S, Young B, Mehrotra R. Patient and Other Stakeholder Engagement in Patient-Centered Outcomes Research Institute Funded Studies of Patients with Kidney Diseases. Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1703-1712. doi: 10.2215/CJN.09780915. Epub 2016 May 19.
Results Reference
background
PubMed Identifier
25954817
Citation
Shah VO, Carroll C, Mals R, Ghahate D, Bobelu J, Sandy P, Colleran K, Schrader R, Faber T, Burge MR. A Home-Based Educational Intervention Improves Patient Activation Measures and Diabetes Health Indicators among Zuni Indians. PLoS One. 2015 May 8;10(5):e0125820. doi: 10.1371/journal.pone.0125820. eCollection 2015.
Results Reference
background
PubMed Identifier
24919064
Citation
Newman S, Cheng T, Ghahate DM, Bobelu J, Sandy P, Faber T, Shah VO. Assessing knowledge and attitudes of diabetes in Zuni Indians using a culture-centered approach. PLoS One. 2014 Jun 11;9(6):e99614. doi: 10.1371/journal.pone.0099614. eCollection 2014.
Results Reference
background
PubMed Identifier
24528897
Citation
Shah VO, Ghahate DM, Bobelu J, Sandy P, Newman S, Helitzer DL, Faber T, Zager P. Identifying barriers to healthcare to reduce health disparity in Zuni Indians using focus group conducted by community health workers. Clin Transl Sci. 2014 Feb;7(1):6-11. doi: 10.1111/cts.12127. Epub 2013 Nov 8.
Results Reference
background
PubMed Identifier
20646805
Citation
MacCluer JW, Scavini M, Shah VO, Cole SA, Laston SL, Voruganti VS, Paine SS, Eaton AJ, Comuzzie AG, Tentori F, Pathak DR, Bobelu A, Bobelu J, Ghahate D, Waikaniwa M, Zager PG. Heritability of measures of kidney disease among Zuni Indians: the Zuni Kidney Project. Am J Kidney Dis. 2010 Aug;56(2):289-302. doi: 10.1053/j.ajkd.2010.03.012. Epub 2010 Jun 19.
Results Reference
background

Learn more about this trial

Home-Based Kidney Care in Native American's of New Mexico (HBKC)

We'll reach out to this number within 24 hrs